{"id":"worldbank.antiretroviral-therapy-coverage.bhr.annual","dataset_id":"worldbank-antiretroviral-therapy-coverage","indicator":"antiretroviral-therapy-coverage","geography":"BHR","frequency":"annual","unit":"percent","start_period":"2000","end_period":"2024","org":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","geography_name":"Bahrain","region":"Middle East, North Africa, Afghanistan & Pakistan","observations":[{"period":"2000","value":7.0,"flags":""},{"period":"2001","value":8.0,"flags":""},{"period":"2002","value":12.0,"flags":""},{"period":"2003","value":12.0,"flags":""},{"period":"2004","value":12.0,"flags":""},{"period":"2005","value":15.0,"flags":""},{"period":"2006","value":17.0,"flags":""},{"period":"2007","value":19.0,"flags":""},{"period":"2008","value":20.0,"flags":""},{"period":"2009","value":21.0,"flags":""},{"period":"2010","value":24.0,"flags":""},{"period":"2011","value":28.0,"flags":""},{"period":"2012","value":30.0,"flags":""},{"period":"2013","value":31.0,"flags":""},{"period":"2014","value":33.0,"flags":""},{"period":"2015","value":35.0,"flags":""},{"period":"2016","value":33.0,"flags":""},{"period":"2017","value":35.0,"flags":""},{"period":"2018","value":46.0,"flags":""},{"period":"2019","value":59.0,"flags":""},{"period":"2020","value":64.0,"flags":""},{"period":"2021","value":55.0,"flags":""},{"period":"2022","value":49.0,"flags":""},{"period":"2023","value":53.0,"flags":""},{"period":"2024","value":55.0,"flags":""}],"indicator_name":"Antiretroviral therapy coverage","topic":"Health","source":"worldbank","provenance":{"organization":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","license":"see source"}}